| 2.05 Data as of May 22 |  +0.09 / +4.59%Today’s Change | 1.14 Today|||52-Week Range 2.77 | +8.47% Year-to-Date |
| Previous close | 1.96 |
| Today’s open | 1.95 |
| Day’s range | 1.95 - 2.09 |
| Volume | 2,235,255 |
| Average volume (3 months) | 1,446,405 |
| Market cap | $298.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -29.41% |
| Earnings growth (this year) | -7.58% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +50.30% |
| P/E ratio | NM |
| Price/Sales | 11.28 |
| Price/Book | 3.61 |
| Today’s change | Today’s % change | |
|---|---|---|
| CRISCuris Inc | -0.18 | -4.64% |
| OSIROsiris Therapeutics ... | +0.13 | +1.20% |
| BTXBioTime Inc | +0.04 | +0.95% |
| OVASOvaScience Inc | -0.15 | -1.23% |
| Next reporting date | August 9, 2013 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $22.1M |
| Annual profit (last year) | -$28.5M |
| Net profit margin | -129.13% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Stanley C. Erck, MBA |
Chief Financial Officer, Treasurer & VP Frederick W. Driscoll |
Corporate headquarters Rockville, Maryland |
.
